ClinicalTrials.govpublic full text
Evaluation Of Switching From Twice Daily Tacrolimus To Once Daily Formulation On Cardiovascular Risk
immunosuppression, cardiovascular diseases, kidney transplantation, prograf®, advagraf®, tacrolimus, kidney transplant, renal transplant, cardiovascular risk, framingham risk, reynolds risk, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 880449
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.